Content |
History
2023: Russian business of pharmaceutical company Eli Lilly transferred to its distributor
The American pharmaceutical company Eli Lilly, specializing in the production of insulin, decided to leave the Russian market and transfer the business to its partner Switzerland , a registered manufacturer. Swixx BioPharma This became known at the end of March 2023. More. here
2022: Pharmgiant Bristol Myers Squibb transfers Russian business to local partner
On May 19, 2022, Bristol Myers Squibb announced its withdrawal from the Russian market. The company transfers the corresponding business to Svix Helskea LLC , a Russian subsidiary of Swiss Swixx BioPharma (engaged in the sale and distribution of medicines and medical devices of international companies in Central and Eastern Europe). Financial and other parameters of the transaction are not disclosed. Read more here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |